These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 4592292)

  • 41. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K; Minges U
    Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
    [No Abstract]   [Full Text] [Related]  

  • 42. Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
    White RH
    Proc R Soc Med; 1967 Nov; 60(11 Part 1):1164-8. PubMed ID: 6060717
    [No Abstract]   [Full Text] [Related]  

  • 43. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of nephrotic syndrome of children with immunosuppressive agents (literature survey)].
    Sergeeva KM; Grinbaum NB
    Vopr Okhr Materin Det; 1975 Nov; 20(11):46-9. PubMed ID: 1220157
    [No Abstract]   [Full Text] [Related]  

  • 45. The nephrotic syndrome in Bantu and Indian patients. A clinicopathological study.
    Seedat YK
    S Afr Med J; 1973 Nov; 47(46):2237-41. PubMed ID: 4128260
    [No Abstract]   [Full Text] [Related]  

  • 46. Nephrotic syndrome: present status.
    Srivastava RN
    Indian Pediatr; 1971 Oct; 8(10):669-71. PubMed ID: 4947597
    [No Abstract]   [Full Text] [Related]  

  • 47. [Catamnestic studies in glomerular kidney diseases as contributions to the pathogenesis of such disease forms].
    Ströder J; Schäfer HE; Holderberg F
    Arztl Forsch; 1967 May; 21(5):155-74. PubMed ID: 4172392
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.
    White RH; Cameron JS; Trounce JR
    Br Med J; 1966 Oct; 2(5518):853-60. PubMed ID: 5917404
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of immunosuppressive treatment of nephrotic syndrome].
    Przybyl L; Salwa-Kubasik W; Urbański K; Wróz M; Hryniewiecki J
    Pol Tyg Lek; 1973 Jun; 28(26):990-3. PubMed ID: 4727614
    [No Abstract]   [Full Text] [Related]  

  • 50. Observations on the "minimal change" lesion: adult onset patients and results of cyclophosphamide treatment in children.
    Cameron JS; Ogg CS; White RH
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():211-6. PubMed ID: 4536423
    [No Abstract]   [Full Text] [Related]  

  • 51. Minimal change lesion with nephrotic syndrome and focal glomerular sclerosis. (Variations of minimal proliferative intercapillary glomerulonephritis with the nephrotic syndrome).
    Bohle A; Fischbach H; Wehner H; Woerz U; Edel HH; Kluthe R; Scheler F
    Clin Nephrol; 1974; 2(2):52-8. PubMed ID: 4830512
    [No Abstract]   [Full Text] [Related]  

  • 52. The nephrotic syndrome: current concepts.
    Ann Intern Med; 1972 Mar; 76(3):463-77. PubMed ID: 4552581
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prognosis of nephrosis].
    Habib R; Kleinknecht C; Gubler MC; Levy M; Guillot M; Gagnadoux MF; Broyer M
    Bol Med Hosp Infant Mex; 1981; 38(3):447-55. PubMed ID: 7271976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
    Drummond KN; Hillman DA; Marchessault JH; Feldman W
    Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chlorambucil in the treatment of idiopathic nephrotic syndrome without glomrular lesions in childhood. Apropos of 30 cases].
    Lévèque B; Debauchez C; Deflandre L; Marie J
    Ann Pediatr (Paris); 1969 Jan; 16(1):13-23. PubMed ID: 5791870
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunosuppressive treatment of corticoid resistant nephrotic syndrome in childhood].
    Boda D; Koltay M; Virág I
    Monatsschr Kinderheilkd (1902); 1969 Feb; 117(2):48-52. PubMed ID: 5399049
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytostatic treatment of glomerular diseases. I. Effect of azathioprine on serum creatinine and proteinuria. Report from a Copenhagen Study Group of Renal Diseases.
    Balslov JT; Brun C; Jensen KB; Jorgensen F; Jorgensen HE; Larsen M; Lorenzen I; Thomsen AC
    Acta Med Scand; 1973 Jun; 193(6):483-91. PubMed ID: 4721957
    [No Abstract]   [Full Text] [Related]  

  • 58. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?
    Gulati S; Sharma AP; Sharma RK; Gupta A; Gupta RK
    Pediatr Nephrol; 2002 Jun; 17(6):404-8. PubMed ID: 12107803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Nephrotic syndrome in the first year of life].
    Kist-van Holthe tot Echten JE; van der Heijden AJ; van der Wiel H; Zoethout HE
    Ned Tijdschr Geneeskd; 1988 Sep; 132(37):1695-9. PubMed ID: 3050557
    [No Abstract]   [Full Text] [Related]  

  • 60. ["Idiopathic" nephrosis in children].
    Bollgren I; Bergstrand A; Laurén T; Samuelsson A; Törnroth T; Wasserman J; Winberg J
    Lakartidningen; 1972 Nov; 69(49):5773-80. PubMed ID: 4568705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.